{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T03:31:02Z","timestamp":1773804662266,"version":"3.50.1"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9S","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Sialorrhea, hyperhidrosis, bromhidrosis, and chromhidrosis are common glandular disorders that substantially impact patients' health and quality of life. Botulinum toxin can safely and temporarily decrease gland secretions by targeting the parasympathetic cholinergic neurons, resulting in diminished saliva and sweat production.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>The objective of this article is to describe the applications of neuromodulators for the treatment of salivary, eccrine, and apocrine glands.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>PubMed was searched from inception to February 1, 2024 using search terms \u201cneurotoxin,\u201d \u201cbotulinum toxin,\u201d \u201csialorrhea,\u201d \u201chyperhidrosis,\u201d \u201cbromhidrosis,\u201d and \u201cchromhidrosis.\u201d<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>Incobotulinumtoxin A and Rimabotulinumtoxin B are approved by the FDA for the treatment of sialorrhea. Onabotulinumtoxin A is the only FDA-approved botulinum toxin for axillary hyperhidrosis and is used off-label for hyperhidrosis of nonaxillary sites, bromhidrosis, and chromhidrosis. Compared to botulinum toxin serotype A, serotype B has been associated with more immunogenicity, which may have implications for patients requiring long-term treatment for chronic glandular disorders.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Neuromodulators are safe and effective for the noninvasive treatment of excess gland activity and can improve patients' quality of life. While substantial literature supports botulinum toxin treatments for hyperhidrosis, further studies are needed to characterize standard dosing and administration techniques for sialorrhea, bromhidrosis, and chromhidrosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000004262","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T23:54:21Z","timestamp":1724889261000},"page":"S103-S111","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Using Neuromodulators for Salivary, Eccrine, and Apocrine Gland Disorders"],"prefix":"10.1097","volume":"50","author":[{"given":"Susruthi","family":"Rajanala","sequence":"first","affiliation":[{"name":"Department of Dermatology, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Salame","sequence":"additional","affiliation":[{"name":"SkinCare Physicians, Chestnut Hill, Massachusetts;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey S.","family":"Dover","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,6,7]]},"reference":[{"key":"R1-20241006","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s40257-022-00743-7","article-title":"The impact of hyperhidrosis on quality of life: a review of the literature","volume":"24","author":"Parashar","year":"2023","journal-title":"Am J Clin Dermatol"},{"key":"R2-20241006","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1600-0714.2008.00727.x","article-title":"Drooling","volume":"38","author":"Scully","year":"2009","journal-title":"J Oral Pathol Med"},{"key":"R3-20241006","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.clindermatol.2015.04.013","article-title":"Hyperhidrosis, bromhidrosis, and chromhidrosis: fold (intertriginous) dermatoses","volume":"33","author":"Semkova","year":"2015","journal-title":"Clin Dermatol"},{"key":"R4-20241006","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s40120-019-00155-6","article-title":"Therapy of sialorrhea with botulinum neurotoxin","volume":"8","author":"Jost","year":"2019","journal-title":"Neurol Ther"},{"key":"R5-20241006","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jaad.2019.11.042","article-title":"Botulinum toxin: pharmacology and injectable administration for the treatment of primary hyperhidrosis","volume":"82","author":"Nawrocki","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R6-20241006","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/DSS.0000000000001906","article-title":"Efficacy and safety of botulinum toxin A in axillary bromhidrosis and associated histological changes in sweat glands: a prospective randomized double-blind side-by-side comparison clinical study","volume":"45","author":"Wu","year":"2019","journal-title":"Dermatol Surg"},{"key":"R7-20241006","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/PRS.0000000000006908","article-title":"Nonaesthetic applications for botulinum toxin in plastic surgery","volume":"146","author":"Freeman","year":"2020","journal-title":"Plast Reconstr Surg"},{"key":"R8-20241006","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jamaneurol.2019.4565","article-title":"Safety and efficacy of RimabotulinumtoxinB for treatment of sialorrhea in adults: a randomized clinical trial","volume":"77","author":"Isaacson","year":"2020","journal-title":"JAMA Neurol"},{"key":"R9-20241006","first-page":"2628","article-title":"Sialorrhea: a management challenge","volume":"69","author":"Hockstein","year":"2004","journal-title":"Am Fam Physician"},{"key":"R10-20241006","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1080\/14737175.2021.1979959","article-title":"A critical review of incobotulinumtoxinA in the treatment of chronic sialorrhea in pediatric patients","volume":"21","author":"Jost","year":"2021","journal-title":"Expert Rev Neurother"},{"key":"R11-20241006","doi-asserted-by":"crossref","first-page":"e1982","DOI":"10.1212\/WNL.0000000000007368","article-title":"SIAXI: placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea","volume":"92","author":"Jost","year":"2019","journal-title":"Neurology"},{"key":"R12-20241006","doi-asserted-by":"crossref","first-page":"e1425","DOI":"10.1212\/WNL.0000000000012573","article-title":"Placebo-controlled clinical trial of IncobotulinumtoxinA for sialorrhea in children: SIPEXI","volume":"97","author":"Berweck","year":"2021","journal-title":"Neurology"},{"key":"R13-20241006","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00784-016-1826-z","article-title":"Does Botulinum neurotoxin type A treatment for sialorrhea change oral health?","volume":"21","author":"Tiigim\u00e4e-Saar","year":"2017","journal-title":"Clin Oral Investig"},{"key":"R14-20241006","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/jcm8030317","article-title":"Effectiveness of the botulinum toxin for treating sialorrhea in patients with Parkinson's disease: a systematic review","volume":"8","author":"Ruiz-Roca","year":"2019","journal-title":"J Clin Med"},{"key":"R15-20241006","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40734-017-0055-1","article-title":"RimabotulinumtoxinB in sialorrhea: systematic review of clinical trials","volume":"4","author":"Dashtipour","year":"2017","journal-title":"J Clin Mov Disord"},{"key":"R27-20241006","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1365-2133.1999.02769.x","article-title":"A randomized, double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosis","volume":"140","author":"Schnider","year":"1999","journal-title":"Br J Dermatol"},{"key":"R28-20241006","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/bmj.323.7313.596","article-title":"Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial","volume":"323","author":"Naumann","year":"2001","journal-title":"BMJ"},{"key":"R29-20241006","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jaad.2007.01.009","article-title":"Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety","volume":"56","author":"Lowe","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R30-20241006","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1067\/mjd.2000.105156","article-title":"Botulinum toxin type A therapy for palmar and digital hyperhidrosis","volume":"42","author":"Solomon","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"R31-20241006","first-page":"822","article-title":"Efficacy and safety of botulinum toxin type a in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled study","volume":"28","author":"Lowe","year":"2002","journal-title":"Dermatol Surg"},{"key":"R32-20241006","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00042728-200503000-00002","article-title":"Double-blind, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for the treatment of palmar hyperhidrosis","volume":"31","author":"Baumann","year":"2005","journal-title":"Dermatol Surg"},{"key":"R33-20241006","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1046\/j.1365-2133.2000.03839.x","article-title":"Effective treatment of frontal hyperhidrosis with botulinum toxin A","volume":"143","author":"Kinkelin","year":"2000","journal-title":"Br J Dermatol"},{"key":"R34-20241006","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/bjd.12568","article-title":"Botulinum toxin for focal hyperhidrosis of the face","volume":"170","author":"George","year":"2014","journal-title":"Br J Dermatol"},{"key":"R35-20241006","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3390\/toxins14060372","article-title":"Botulinum toxin type A for treatment of forehead hyperhidrosis: multicenter clinical experience and review from literature","volume":"14","author":"Campanati","year":"2022","journal-title":"Toxins (Basel)"},{"key":"R36-20241006","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00702-013-1074-1","article-title":"Onabotulinumtoxin type A (Botox) versus Incobotulinumtoxin type A (Xeomin) in the treatment of focal idiopathic palmar hyperhidrosis: results of a comparative double-blind clinical trial","volume":"121","author":"Campanati","year":"2014","journal-title":"J Neural Transm (Vienna)"},{"key":"R37-20241006","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1365-2133.2003.05620.x","article-title":"A double-blind, randomized, comparative study of Dysport vs Botox in primary palmar hyperhidrosis","volume":"149","author":"Simonetta Moreau","year":"2003","journal-title":"Br J Dermatol"},{"key":"R42-20241006","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archderm.139.1.57","article-title":"Amelioration of body odor after intracutaneous axillary injection of botulinum toxin A","volume":"139","author":"Heckmann","year":"2003","journal-title":"Arch Dermatol"},{"key":"R43-20241006","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s00266-018-1075-4","article-title":"Long-term safety and efficacy of botulinum toxin A treatment in adolescent patients with axillary bromhidrosis","volume":"42","author":"Wang","year":"2018","journal-title":"Aesthet Plast Surg"},{"key":"R45-20241006","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/00042728-200508000-00014","article-title":"Botulinum toxin a in the treatment of chromhidrosis","volume":"31","author":"Wu","year":"2005","journal-title":"Dermatol Surg"},{"key":"R46-20241006","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jaad.2004.08.024","article-title":"Treatment of facial chromhidrosis with botulinum toxin type A","volume":"52","author":"Matarasso","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R47-20241006","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1473-2165.2010.00530.x","article-title":"Axillary chromhidrosis: report of a case, review of the literature and treatment considerations","volume":"9","author":"Beer","year":"2010","journal-title":"J Cosmet Dermatol"},{"key":"R16-20241006","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00702-015-1416-2","article-title":"The option of sonographic guidance in Botulinum toxin injection for drooling in Parkinson's disease","volume":"123","author":"Jost","year":"2016","journal-title":"J Neural Transm (Vienna)"},{"key":"R17-20241006","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.clineuro.2003.10.012","article-title":"Ultrasound-guided versus 'blind' intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease","volume":"106","author":"Dogu","year":"2004","journal-title":"Clin Neurol Neurosurg"},{"key":"R18-20241006","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5535\/arm.2017.41.1.51","article-title":"Accuracy of ultrasound-guided and non-ultrasound-guided botulinum toxin injection into cadaver salivary glands","volume":"41","author":"So","year":"2017","journal-title":"Ann Rehabil Med"},{"key":"R19-20241006","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00005537-200301000-00020","article-title":"The treatment of drooling by ultrasound-guided intraglandular injections of botulinum toxin type A into the salivary glands","volume":"113","author":"Jongerius","year":"2003","journal-title":"Laryngoscope"},{"key":"R20-20241006","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/09546634.2017.1309347","article-title":"Axillary hyperhidrosis: a focused review","volume":"28","author":"Sammons","year":"2017","journal-title":"J Dermatolog Treat"},{"key":"R21-20241006","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jaad.2018.11.066","article-title":"The etiology, diagnosis, and management of hyperhidrosis: a comprehensive review: therapeutic options","volume":"81","author":"Nawrocki","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"R22-20241006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.1951.sp004551","article-title":"A further survey of the action of Clostridium botulinum toxin upon different types of autonomic nerve fibre","volume":"113","author":"Ambache","year":"1951","journal-title":"J Physiol"},{"key":"R23-20241006","doi-asserted-by":"crossref","first-page":"e32764","DOI":"10.1097\/MD.0000000000032764","article-title":"Treatment of hyperhidrosis with Botox (onabotulinumtoxinA): development, insights, and impact","volume":"102","author":"Lowe","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"R24-20241006","first-page":"AB61","article-title":"Four-year longitudinal data on the efficacy and safety of repeated botulinum toxin type A therapy for primary axillary hyperhidrosis [abstract]","volume":"56","author":"Glaser","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R25-20241006","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/diseases12010015","article-title":"Assessing botulinum toxin effectiveness and quality of life in axillary hyperhidrosis: a one-year prospective study","volume":"12","author":"Castiglione","year":"2024","journal-title":"Diseases"},{"key":"R26-20241006","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/1090820X11434506","article-title":"Treatment of hyperhidrosis with botulinum toxin","volume":"32","author":"Doft","year":"2012","journal-title":"Aesthet Surg J"},{"key":"R38-20241006","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.det.2014.06.001","article-title":"Botulinum toxin for hyperhidrosis of areas other than the axillae and palms\/soles","volume":"32","author":"Glaser","year":"2014","journal-title":"Dermatol Clin"},{"key":"R39-20241006","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/DSS.0000000000003441","article-title":"Ancillary techniques to relieve the pain associated with botulinum injections for palmar and plantar hyperhidrosis","volume":"48","author":"Matarasso","year":"2022","journal-title":"Dermatol Surg"},{"key":"R40-20241006","doi-asserted-by":"crossref","first-page":"7784","DOI":"10.1039\/D3BM01301D","article-title":"Botulinum toxin A dissolving microneedles for hyperhidrosis treatment: design, formulation and in vivo evaluation","volume":"11","author":"Malek-Khatabi","year":"2023","journal-title":"Biomater Sci"},{"key":"R41-20241006","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/12034754231191062","article-title":"Therapeutic effectiveness of needle injection versus needle-free jet injector system for botulinum toxin type A in palmar hyperhidrosis","volume":"27","author":"Watanabe","year":"2023","journal-title":"J Cutan Med Surg"},{"key":"R44-20241006","doi-asserted-by":"crossref","first-page":"13030\/qt27v774t5","DOI":"10.5070\/D3249041410","article-title":"Genital rejuvenation: the next frontier in medical and cosmetic Dermatology","volume":"24","author":"Cohen","year":"2018","journal-title":"Dermatol Online J"}],"updated-by":[{"DOI":"10.1097\/dss.0000000000004517","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000}}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004262","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,6]],"date-time":"2024-10-06T03:14:16Z","timestamp":1728184456000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,7]]},"references-count":47,"journal-issue":{"issue":"9S","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000004262","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,7]]}}}